SCRI - Colorado Blood Cancer Institute (CBCI) — Denver, Colorado

SCRI - Colorado Blood Cancer Institute (CBCI) is a clinical research site located in Denver, Colorado, United States 92037.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI - Colorado Blood Cancer Institute (CBCI) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Lymphoma, T-Cell.

Sponsors: March Biosciences Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI - Colorado Blood Cancer Institute (CBCI)?

SCRI - Colorado Blood Cancer Institute (CBCI) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI - Colorado Blood Cancer Institute (CBCI) conducted?

SCRI - Colorado Blood Cancer Institute (CBCI) has 1 clinical trials on record, with 1 currently active. Their work covers Lymphoma, T-Cell.

Is SCRI - Colorado Blood Cancer Institute (CBCI) accredited by Crixeo Health?

SCRI - Colorado Blood Cancer Institute (CBCI) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI - Colorado Blood Cancer Institute (CBCI)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.